Literature DB >> 2156791

The 25.2 MDa tetracycline-resistance plasmid is not derived from the 24.5 MDa conjugative plasmid of Neisseria gonorrhoeae.

D M Gascoyne1, J Heritage, P M Hawkey.   

Abstract

High-level tetracycline resistance in strains of Neisseria gonorrhoeae is due to the presence of a 25.2 MDa conjugative plasmid. This plasmid has been shown to carry the streptococcal tetM determinant, and has been thought to have evolved from the 24.5 MDa conjugative plasmid found in N. gonorrhoeae. We have derived a physical map of the 25.2 MDa plasmid pUS100 using seven restriction endonucleases. Comparison of the physical map with the previously published physical map of the conjugative plasmid pLE2451 shows there to be no obvious similarity between the two plasmids. The location of the tetM determinant has been established, by Southern hybridization, confirming the restriction endonuclease map. This has also provided evidence that the transposition functions normally associated with the tetM determinant have been lost.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156791     DOI: 10.1093/jac/25.1.39

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  World-wide distribution of high level tetracycline-resistant Neisseria gonorrhoeae.

Authors:  D M Gascoyne-Binzi; P M Hawkey; J Heritage; A Turner; M Nadarajah
Journal:  Genitourin Med       Date:  1992-08

Review 2.  The changing pattern of antibiotic resistance of Neisseria gonorrhoeae.

Authors:  C S Easmon
Journal:  Genitourin Med       Date:  1990-04

3.  Antimicrobial susceptibility of Neisseria gonorrhoeae in Zaire: high level plasmid-mediated tetracycline resistance in central Africa.

Authors:  E Van Dyck; R Rossau; M Duhamel; F Behets; M Laga; M Nzila; S Bygdeman; H Van Heuverswijn; P Piot
Journal:  Genitourin Med       Date:  1992-04

4.  Conjugative plasmids of Neisseria gonorrhoeae.

Authors:  Emilia Pachulec; Chris van der Does
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.